• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines

Introduction to 6-methyl-3-phenylpicolinic acid (CAS No: 1228430-85-0)

6-methyl-3-phenylpicolinic acid, identified by the Chemical Abstracts Service Number (CAS No) 1228430-85-0, is a heterocyclic organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to the pyridine carboxylic acid class, characterized by a pyridine ring substituted with a methyl group at the 6-position and a phenyl group at the 3-position, linked to a carboxylic acid moiety. The unique structural features of 6-methyl-3-phenylpicolinic acid make it a versatile scaffold for exploring novel biological activities and therapeutic potential.

The synthesis of 6-methyl-3-phenylpicolinic acid typically involves multi-step organic reactions, often starting from readily available pyridine derivatives. The introduction of the methyl and phenyl substituents requires precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions, have been employed to enhance the efficiency of these transformations. The structural integrity of the compound is crucial for its biological evaluation, necessitating rigorous analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and high-performance liquid chromatography (HPLC) for confirmation.

In recent years, 6-methyl-3-phenylpicolinic acid has been studied for its potential pharmacological properties. Its molecular structure suggests possible interactions with various biological targets, making it a promising candidate for drug discovery. Preliminary in vitro studies have indicated that this compound may exhibit inhibitory effects on certain enzymes and receptors, which are relevant to metabolic disorders and inflammatory diseases. The phenyl group, in particular, has been shown to modulate binding affinity and selectivity, a critical factor in drug design.

One of the most intriguing aspects of 6-methyl-3-phenylpicolinic acid is its role as a precursor in the development of more complex derivatives. By modifying its functional groups or introducing additional heterocycles, researchers can generate novel molecules with enhanced biological activity. For instance, derivatives of this compound have been explored for their potential in treating neurological disorders, where precise targeting of neuronal pathways is essential. The versatility of 6-methyl-3-phenylpicolinic acid as a scaffold underscores its importance in medicinal chemistry.

The pharmacokinetic properties of 6-methyl-3-phenylpicolinic acid are also under investigation. Understanding how the body processes this compound is vital for optimizing its therapeutic use. Studies have begun to explore its absorption, distribution, metabolism, and excretion (ADME) profiles using both computational modeling and experimental methods. These insights are crucial for designing prodrugs or formulations that enhance bioavailability and reduce toxicity.

Furthermore, the environmental impact of 6-methyl-3-phenylpicolinic acid has not been overlooked. Research into its biodegradability and potential ecological effects is essential for ensuring sustainable practices in pharmaceutical development. Efforts are being made to synthesize this compound using greener methodologies, such as solvent-free reactions or catalytic processes that minimize waste generation.

The intersection of chemistry and biology has led to exciting discoveries involving 6-methyl-3-phenylpicolinic acid. Its ability to interact with biological systems at multiple levels makes it a valuable tool for understanding disease mechanisms and developing innovative treatments. As research progresses, new applications for this compound are likely to emerge, further solidifying its role in modern medicine.

In conclusion,6-methyl-3-phenylpicolinic acid (CAS No: 1228430-85-0) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structure, combined with its observed biological activities, positions it as a key molecule for future drug development. Continued investigation into its properties and applications will undoubtedly yield further advancements in health care.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)